Loading data for BLLN — first visit, this takes a few seconds.

알림

BillionToOne Inc. (BLLN)

NasdaqGS: BLLN · 실시간 가격 · USD

91.40

+3.41 (3.88%)

종가 기준: Aug 17, 2026, 8:00 PM

3.88% (1D)

데이터 없음

매수호가	66.51
시가총액	4.43B
매출 (ttm)	397.41M
순이익 (ttm)	33.18M
베타	n/a
EPS (ttm)	0.72
P/E (ttm)	130.43
선행 P/E	70.61
P/B (ttm)	8.19
P/S (ttm)	11.15
Earnings Date	Nov 5, 2026

매도호가	115.2
거래량	277,966
평균 거래량 (20일)	768,258
시가	89.87
전일 종가	87.99
일중 범위	89.19 - 94.25
52주 범위	61.96 - 150.44
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

BLLN 소개

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Norths...

[더 보기]

산업 Diagnostics & Research

섹터 Healthcare

IPO 일자 Nov 6, 2025

직원 수 713

상장 거래소 NasdaqGS

티커 BLLN

웹사이트 https://www.billiontoone.com

전체 기업 정보

재무 실적

2025년 BillionToOne의 매출은 305.11M로, 전년 n/a 대비 undefined% 증가했습니다. 순이익은 7.45M로, undefined% 증가했습니다.

재무제표

어닝 서프라이즈

BillionToOne가 Aug 5, 2026에 분기 실적을 발표했습니다:

매출 $109.45M 예상치 하회 $0, 및 64.40% 전년 대비 성장.

EPS 0.36 예상치 상회 0.20, 및 Infinity% 전년 대비 성장.

다음 실적 발표

BillionToOne Inc.의 실적 발표 예정일은 Nov 5, 2026, 정규장 중입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

1주 전 · Investor's Business Daily

Why BillionToOne Plummeted 38%, Leading A Medtech Sell-Off

Medical research stocks took a bath Thursday, helped by BillionToOne's second-quarter report, featuring a beat but no guidance raise.

1주 전 · Simply Wall St.

Can BillionToOne (BLLN) Justify Its Price On Earnings And Reaffirmed 2026 Guidance?

BillionToOne (BLLN) is back in focus after its August 5 update, when the company reported second quarter 2026 results and reaffirmed its full-year revenue outlook in the mid US$400 million range. See ...

1주 전 · Moby

BillionToOne, Inc. Q2 2026 Earnings Call Summary

Moby summary of BillionToOne, Inc.'s Q2 2026 earnings call

1주 전 · GuruFocus.com

BillionToOne Inc (BLLN) (Q2 2026) Earnings Call Highlights: Revenue Surges 64% as Oncology and ...

BillionToOne Inc (BLLN) posts strong Q2 with record revenue, expanding margins, and strategic momentum in oncology and prenatal testing.

1주 전 · Zacks

BillionToOne (BLLN) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for BillionToOne (BLLN) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compa...

2 페이지 중 1

BillionToOne Inc. (BLLN)